Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of Cord Blood-derived CAR NK Cells Targeting CD19/CD70 in Refractory/Relapsed B-cell Non-Hodgkin Lymphoma

NCT05842707 is registered in ClinicalTrials.gov with Aibin Liang，MD，Ph.D. as lead sponsor.

NCT NCT05842707
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05842707 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of Cord Blood-derived CAR NK Cells Targeting CD19/CD70 in Refractory/Relapsed B-cell Non-Hodgkin Lymphoma
Lead sponsor
Aibin Liang，MD，Ph.D.
Phase
Phase 1/2
Overall status
Recruiting
Start date
January 18, 2023
Completion date
January 18, 2029
Enrollment
48 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

refractory or relapsed b-cell non-hodgkin lymphoma